Literature DB >> 1996981

The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues.

K Ohta1, T Endo, T Onaya.   

Abstract

Expression levels of thyrotropin receptor (TSH-R), thyroglobulin (Tg) and thyroid peroxidase (TPO) mRNA in normal and neoplastic human thyroid tissues (6 adenomas and 7 carcinomas) were investigated by Northern-blot and slot-blot analyses. We found that TSH-R mRNA levels were significantly lower in carcinoma tissues than in normal tissues. The levels of Tg mRNA were also significantly lowered in adenoma and carcinoma tissues as compared to normal tissues. In contrast, no significant difference was observed in the expression levels of TPO mRNA between these tissues. Furthermore, TSH-R mRNA levels were well-correlated with Tg mRNA levels in neoplastic tissues. These results suggest that mRNAs of TSH-R and Tg are expressed in relation to their degree of differentiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996981     DOI: 10.1016/0006-291x(91)91540-s

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Pax-8-PPAR-γ fusion protein in thyroid carcinoma.

Authors:  Priyadarshini Raman; Ronald J Koenig
Journal:  Nat Rev Endocrinol       Date:  2014-07-29       Impact factor: 43.330

Review 2.  Immunity to the thyroid-stimulating hormone receptor.

Authors:  J Furmaniak; B R Smith
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors.

Authors:  Svetlana Savin; Dubravka Cvejic; Tijana Isic; Ivana Petrovic; Ivan Paunovic; Svetislav Tatic; Marija Havelka
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

4.  Current trends in TSH suppression therapy for patients with papillary thyroid carcinoma in Japan: results of a questionnaire distributed to councilors of the Japanese Society of Thyroid Surgery.

Authors:  Katsuhiro Tanaka; Hiroshi Sonoo
Journal:  Surg Today       Date:  2011-12-17       Impact factor: 2.549

Review 5.  The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.

Authors:  Takahiko Kogai; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2012-06-29       Impact factor: 12.310

6.  Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.

Authors:  T Saito; T Endo; A Kawaguchi; M Ikeda; R Katoh; A Kawaoi; A Muramatsu; T Onaya
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

7.  Influence of TSH on uptake of [18F]fluorodeoxyglucose in human thyroid cells in vitro.

Authors:  J T Deichen; C Schmidt; O Prante; S Maschauer; T Papadopoulos; T Kuwert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

8.  Transforming growth factor-beta 1 is more expressed in thyroid follicular adenoma than in normal tissue.

Authors:  P Morosini; A Taccaliti; C Di Loreto; G Arnaldi; E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

9.  Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R.

Authors:  K Tanaka; H Inoue; H Miki; E Masuda; M Kitaichi; K Komaki; T Uyama; Y Monden
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Effect of recombinant human thyrotropin on the uptake of radioactive iodine (¹²³I) in dogs with thyroid tumors.

Authors:  Miguel Campos; Kathelijne Peremans; Eva Vandermeulen; Luc Duchateau; Tim Bosmans; Ingeborgh Polis; Sylvie Daminet
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.